| Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes … WH Seligman, L Fialho, N Sillett, C Nielsen, FM Baloch, P Collis, ... BMJ open 11 (11), e051065, 2021 | 10 | 2021 |
| Contemporary challenges for specialist nursing in interstitial lung disease AM Russell, S Olive, S Lines, A Murphy, J Hocking, K Newell, H Morris, ... Breathe 14 (1), 36-41, 2018 | 10 | 2018 |
| Physiotherapy assessment of breathing pattern disorder: a qualitative evaluation L Grillo, AM Russell, H Shannon, A Lewis BMJ Open Respiratory Research 10 (1), e001395, 2023 | 9 | 2023 |
| World Health Organization (WHO) international classification of functioning, disability and health (ICF) core set development for interstitial lung disease LA Saketkoo, R Escorpizo, J Varga, KJ Keen, K Fligelstone, SS Birring, ... Frontiers in Pharmacology 13, 979788, 2022 | 9 | 2022 |
| AmbOx: a randomised controlled, crossover trial evaluating the effects of ambulatory oxygen on health status in patients with fibrotic interstitial lung disease D Visca, L Mori, V Tsipouri, S Canu, M Bonini, M Pavitt, S Fleming, ... B14. CLINICAL TRIALS ACROSS PULMONARY DISEASE, A7603-A7603, 2017 | 8 | 2017 |
| Non-pharmacological treatment of idiopathic pulmonary fibrosis HI Adamali, MS Anwar, AM Russell, JJ Egan Current Respiratory Care Reports 1, 208-215, 2012 | 8 | 2012 |
| Ageing with Interstitial lung disease: preserving health and well being LA Saketkoo, ON Obi, KC Patterson, AM Russell Current Opinion in Pulmonary Medicine 28 (4), 321-336, 2022 | 7 | 2022 |
| Correlation between home and clinic spirometry in subjects with IPF: results from the INMARK trial T Maher, V Cottin, AM Russell, T Corte, P Hammerl, A Michael, KB Rohr, ... European Respiratory Journal 54 (suppl 63), 2019 | 7 | 2019 |
| P276 Development of patient reported experience measure (PREM) for idiopathic pulmonary fibrosis (IPF) W ACCELEROMETERS Thorax 71 (3), A1-A288, 2016 | 7 | 2016 |
| Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better? AM Russell, TM Maher Respirology 19 (8), 1095-1096, 2014 | 7 | 2014 |
| Interstitial lung disease and specialist palliative care access: a healthcare professionals survey JW Kim, S Olive, S Jones, M Thillai, AM Russell, MJ Johnson, A Wilson BMJ Supportive & Palliative Care 12 (e6), e748-e751, 2022 | 6 | 2022 |
| Development and preliminary testing of the idiopathic pulmonary fibrosis patient reported outcome measure (IPF-PRoM): UK and Ireland multi-centre study AM Russell, G Jones, L Saketkoo, AM Doyle, T Sanderson, C D'Accord, ... A17. MEASUREMENT OF SYMPTOMS AND FUNCTION, A1031-A1031, 2017 | 6 | 2017 |
| The respiratory microbiome in idiopathic pulmonary fibrosis PL Molyneaux, AM Russell, MJ Cox, MF Moffatt, WO Cookson, TM Maher C103. pathogenesis, biomarkers, and risk factors for interstitial lung …, 2012 | 6 | 2012 |
| Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease D Visca, R Centis, E Pontali, E Zampogna, AM Russell, GB Migliori, ... The International Journal of Tuberculosis and Lung Disease 27 (10), 729-741, 2023 | 5 | 2023 |
| SingStrong–singing for better lung health in pulmonary fibrosis: A feasibility study R Cahalan, AM Russell, C Meade, G Hayes Physiotherapy Practice and Research 43, 17-25, 2022 | 5 | 2022 |
| Fibrotic interstitial lung disease-palliative care needs: a World-Café qualitative study N Cassidy, L Fox, M Love, I Byrne, AM Doyle, B Korn, D Shanagher, ... BMJ Supportive & Palliative Care, 2021 | 5 | 2021 |
| An ode to the primal tonic of dance—congratulating the Life of Breath project LA Saketkoo, H Alexanderson, MR Lammi, D LeSage, K Jensen, ... The Lancet Respiratory Medicine 8 (12), e90-e91, 2020 | 5 | 2020 |
| Daily home spirometry: a new milestone in the field of pulmonary fibrosis WA Wuyts, P Spagnolo, F Bonella, J Yserbyt, GM Verleden American journal of respiratory and critical care medicine 194 (8), 1033-1034, 2016 | 5 | 2016 |
| The PROFILE study: a prospective study of fibrosis in lung endpoints to discover and qualify biomarkers for use in clinical trials G Saini, G Jenkins, T Mckeever, J Simpson, R Hubbard, S Johnson, ... C103. PATHOGENESIS, biomarkers, and risk factors for interstitial lung …, 2012 | 5 | 2012 |
| Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment MA Althobiani, AM Russell, J Jacob, Y Ranjan, AA Folarin, JR Hurst, ... Frontiers in Medicine 11, 1296890, 2024 | 4 | 2024 |
Huzaifa I AdamaliBristol Interstitial Lung Disease (BILD) Service, North Bristol Lung Center, SouthmeadVerified email at nbt.nhs.uk